NCT06395519
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06395519
Title A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (ERADIC8)
Acronym ERADIC8
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors 858 Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic RECRUITING Phoenix Arizona 85054 United States Details
Yale University, Yale Cancer Center RECRUITING New Haven Connecticut 06510 United States Details
Mayo Clinic RECRUITING Jacksonville Florida 32224 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center RECRUITING Philadelphia Pennsylvania 19107 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
START Center for Cancer Care - Mountain Region RECRUITING Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field